EFTR logo

EFTR

Profile

Full Name

eFFECTOR Therapeutics, Inc.

Ticker Symbol

NASDAQ: EFTR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 1, 2021

Indexes

Not included

Website

http://effector.com

Employees

14

Key Details

Price

$0.00(-33.33%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$16.37(-18.97% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.00
    EFTR price is $0.00

    30-Day Relative Volume

    0.64
    EFTR 30-day relative volume is 0.64

    Price Performance

    Price Most recent change

    -33.33%
    EFTR price was down -33.33% on Jul 3, 2025

    Price YTD change

    0%
    EFTR {parameterFullLabel} has remained unchanged since January 1st

    Price 1-year change

    -99.85%
    EFTR price is down -99.85% year-on-year

    Price 3-year change

    -100%
    EFTR price is down -100% over the past 3 years

    Price Range

    Price All-time high

    $1010.50
    EFTR price is currently -100.00% below its historical high of $1010.50

    Price 3-year low

    $0.00
    EFTR price is currently +100.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $940.88
    EFTR market capitalization is $940.88

    Market cap 3-year change

    -100%
    EFTR market capitalization is down -100% over the past 3 years

    Market cap All-time high

    $1.10B
    EFTR market capitalization is currently -100.00% below its historical high of $1.10 billion

    Market cap sector rank

    0.74%
    EFTR market capitalization is higher than 0.74% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    EFTR {parameterFullLabel} has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +185.79%
    EFTR shares outstanding is up +185.79% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -1.58
    EFTR beta is -1.58

    200-day SMA

    $0.00
    EFTR price is currently -95.45% below its 200-day simple moving average

    50-day SMA

    $0.00
    EFTR price is currently -33.33% below its 50-day simple moving average

    RSI

    50.00
    EFTR 14-day relative strength index is 50.00

    Volume

    0.64
    EFTR 30-day relative volume is 0.64

    ATR

    $0.00
    EFTR average true range is $0.00

    10-day Historical Volatility

    167.32%
    EFTR 10-day historical volatility is 167.32%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    EFTR annual revenue value is unknown

    Revenue Analysts estimate

    -
    EFTR annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    EFTR annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    EFTR annual revenue is unknown

    EPS

    EPS

    -$16.37
    EFTR annual earnings per share is -$16.37

    EPS Analysts estimate

    -$6.17
    EFTR annual earnings per share is currently +165.32% higher than the consensus analysts' forecast

    EPS 1-year change

    -18.97%
    EFTR annual earnings per share is down -18.97% year-on-year

    EPS Sector rank

    8.9%
    EFTR annual earnings per share is higher than 8.9% of companies in Healthcare sector

    Profit

    Gross profit

    -
    EFTR annual gross profit value is unknown

    Gross margin

    -
    EFTR annual gross profit margin value is unknown

    Operating profit

    -$33.84M
    EFTR annual operating income is -$33.84 million

    Operating margin

    -
    EFTR annual operating profit margin value is unknown

    Net income

    -$35.81M
    EFTR annual net profit is -$35.81 million

    Net margin

    -
    EFTR annual net profit margin value is unknown

    Expenses

    Total expenses

    $33.84M
    EFTR annual total expenses is $33.84 million

    Operating expenses

    $33.84M
    EFTR annual total operating expenses is $33.84 million

    Cost of goods sold

    -
    EFTR annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $10.93M
    EFTR annual SGA is $10.93 million

    Depreciation and amortization

    $111.00K
    EFTR annual depreciation & amortization is $111.00 thousand

    Interest expense

    $2.92M
    EFTR annual interest expense is $2.92 million

    Income tax

    -
    EFTR annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$32.89M
    EFTR annual earnings before interest & taxes is -$32.89 million

    EBITDA

    -$32.78M
    EFTR annual EBITDA is -$32.78 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $20.54M
    EFTR annual total assets is $20.54 million

    Non current assets

    $706.00K
    EFTR annual long term assets is $706.00 thousand

    Current assets

    $19.84M
    EFTR annual total current assets is $19.84 million

    Cash and cash equivalents

    $14.88M
    EFTR annual cash & cash equivalents is $14.88 million

    Accounts receivable

    -
    EFTR annual accounts receivable value is unknown

    Inventory

    -
    EFTR annual inventory value is unknown

    Liabilities

    Total liabilities

    $26.34M
    EFTR annual total liabilities is $26.34 million

    Long term liabilities

    $543.00K
    EFTR annual total long term liabilities is $543.00 thousand

    Current liabilities

    $25.80M
    EFTR annual total current liabilities is $25.80 million

    Accounts payable

    $2.33M
    EFTR annual accounts payable is $2.33 million

    Debt

    Total debt

    $20.55M
    EFTR annual total debt is $20.55 million

    Total debt 1-year change

    +1.3%
    EFTR annual total debt is up +1.3% year-on-year

    Long term debt

    $0.00
    EFTR annual long term debt is $0.00

    Short term debt

    $20.55M
    EFTR annual short term debt is $20.55 million

    Equity & Capital

    Shareholders equity

    -$5.79M
    EFTR annual stockholders equity is -$5.79 million

    Book value

    -$5.79M
    EFTR annual book value is -$5.79 million

    Retained earnings

    -$179.38M
    EFTR annual retained earnings is -$179.38 million

    Working capital

    -$5.96M
    EFTR annual working capital is -$5.96 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$29.55M
    EFTR annual cash flow from operations is -$29.55 million

    Cash from operations 1-year change

    -14.1%
    EFTR annual cash flow from operations is down -14.1% year-on-year

    Cash from investing

    $14.48M
    EFTR annual cash flow from investing activities is $14.48 million

    Cash from investing 1-year change

    +181.1%
    EFTR annual cash flow from investing activities is up +181.1% year-on-year

    Cash from financing

    $21.23M
    EFTR annual cash flow from financing activities is $21.23 million

    Cash from financing 1-year change

    +667.92%
    EFTR annual cash flow from financing activities is up +667.92% year-on-year

    CAPEX

    CAPEX

    -
    EFTR annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    EFTR annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$29.65M
    EFTR annual free cash flow is -$29.65 million

    Free cash flow 1-year change

    -13.63%
    EFTR annual free cash flow is down -13.63% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    EFTR annual gross profit margin value is unknown

    Operating margin

    -
    EFTR annual operating profit margin value is unknown

    Net margin

    -
    EFTR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -174.31%
    EFTR annual return on assets is -174.31%

    ROE

    617.96%
    EFTR annual return on equity is 617.96%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    EFTR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    EFTR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.00
    EFTR price to book ratio is 0.00

    PB ratio Sector rank

    16.91%
    EFTR price to book ratio is higher than 16.91% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    EFTR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    EFTR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $4.74M
    EFTR enterprise value is $4.74 million

    Enterprise value Sector rank

    17.62%
    EFTR enterprise value is higher than 17.62% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.15
    EFTR EV/EBITDA is -0.15

    EV/EBITDA Sector rank

    62.18%
    EFTR EV/EBITDA is higher than 62.18% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.77
    EFTR annual current ratio is 0.77

    Quick ratio

    -
    EFTR annual quick ratio value is unknown

    Leverage

    Debt to equity

    -3.55
    EFTR annual debt to equity ratio is -3.55

    Interest coverage ratio

    -11.27
    EFTR annual interest coverage ratio is -11.27

    Risk & Stability

    Piotroski F-Score

    -
    EFTR piotroski f-score value is unknown

    Altman Z-Score

    -
    EFTR altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Mar 28, 24 HC Wainwright & Co.
    Buy
    Feb 6, 24 HC Wainwright & Co.
    Buy
    Nov 14, 23 HC Wainwright & Co.
    Buy
    Aug 24, 23 HC Wainwright & Co.
    Buy
    May 26, 23 Stifel
    Buy
    May 10, 23 Credit Suisse
    Outperform
    Mar 9, 23 Credit Suisse
    Outperform
    Jan 9, 23 JMP Securities
    Market Outperform
    Jan 6, 23 Credit Suisse
    Outperform
    Nov 17, 22 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with EFTR included

    Stocks cheaper than 1 dollar
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for eFFECTOR Therapeutics, Inc.?
    • Does eFFECTOR Therapeutics, Inc. pay dividends?
    • What sector is eFFECTOR Therapeutics, Inc. in?
    • What industry is eFFECTOR Therapeutics, Inc. in?
    • What country is eFFECTOR Therapeutics, Inc. based in?
    • When did eFFECTOR Therapeutics, Inc. go public?
    • Is eFFECTOR Therapeutics, Inc. in the S&P 500?
    • Is eFFECTOR Therapeutics, Inc. in the NASDAQ 100?
    • Is eFFECTOR Therapeutics, Inc. in the Dow Jones?
    • When was eFFECTOR Therapeutics, Inc.'s last earnings report?
    • When does eFFECTOR Therapeutics, Inc. report earnings?

    What is the ticker symbol for eFFECTOR Therapeutics, Inc.?

    The ticker symbol for eFFECTOR Therapeutics, Inc. is NASDAQ:EFTR

    Does eFFECTOR Therapeutics, Inc. pay dividends?

    No, eFFECTOR Therapeutics, Inc. does not pay dividends

    What sector is eFFECTOR Therapeutics, Inc. in?

    eFFECTOR Therapeutics, Inc. is in the Healthcare sector

    What industry is eFFECTOR Therapeutics, Inc. in?

    eFFECTOR Therapeutics, Inc. is in the Biotechnology industry

    What country is eFFECTOR Therapeutics, Inc. based in?

    eFFECTOR Therapeutics, Inc. is headquartered in United States

    When did eFFECTOR Therapeutics, Inc. go public?

    eFFECTOR Therapeutics, Inc.'s initial public offering (IPO) was on March 1, 2021

    Is eFFECTOR Therapeutics, Inc. in the S&P 500?

    No, eFFECTOR Therapeutics, Inc. is not included in the S&P 500 index

    Is eFFECTOR Therapeutics, Inc. in the NASDAQ 100?

    No, eFFECTOR Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is eFFECTOR Therapeutics, Inc. in the Dow Jones?

    No, eFFECTOR Therapeutics, Inc. is not included in the Dow Jones index

    When was eFFECTOR Therapeutics, Inc.'s last earnings report?

    eFFECTOR Therapeutics, Inc.'s most recent earnings report was on May 9, 2024

    When does eFFECTOR Therapeutics, Inc. report earnings?

    The date for eFFECTOR Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page